MyMedR

Displaying all 7 publications

Abstract:

Sort:

Managing complications of radiation therapy in head and neck cancer patients: Part V. Management of mucositis

Ngeow WC, Chai WL, Rahman RA, Ramli R

Singapore Dent J, 2006 Dec;28(1):16-8.
PMID: 17378337

Head and neck cancer is becoming a more recognizable pathology to the general population and dentists. The modes of treatment include surgery and/or radiation therapy. Where possible, pretreatment dental assessment shall be provided for these patients before they undergo radiation therapy. There are occasions, however, whereby head and neck cancer patients are not prepared optimally for radiation therapy. Because of this, they succumb to complicated oral adverse effects after radiation therapy. The second last part of this series reviews and discusses the management of complication that commonly occur to the oral mucosa, i.e. mucositis.

Matched MeSH terms: Radiation Injuries/therapy*
Managing complications of radiation therapy in head and neck cancer patients: Part I. Management of xerostomia

Ngeow WC, Chai WL, Rahman RA, Ramli R

Singapore Dent J, 2006 Dec;28(1):1-3.
PMID: 17378333

Head and neck cancer is becoming a more recognizable pathology to the general population and dentists. The modes of treatment include surgery and/or radiation therapy. Where possible, pretreatment dental assessment shall be provided for these patients before they receive radiation therapy. There are occasions, however, whereby head and neck cancer patients are not prepared optimally for radiation therapy. Because of this, they succumb to complicated oral adverse effects after radiation therapy. Part I of this series reviews the management of xerostomia. The management of the effect of xerostomia to the dentition/oral cavity is discussed in Part II.

Matched MeSH terms: Radiation Injuries/therapy*
Topical application of honey in the management of radiation mucositis: a preliminary study

Biswal BM, Zakaria A, Ahmad NM

Support Care Cancer, 2003 Apr;11(4):242-8.
PMID: 12673463

BACKGROUND: The aim of this study was to evaluate the effect of pure natural honey on radiation-induced mucositis.
PATIENTS AND METHODS: Forty patients diagnosed with head and neck cancer requiring radiation to the oropharyngeal mucosal area were divided in to two groups to receive either radiation alone or radiation plus topical application of pure natural honey. Patients were treated using a 6-MV linear accelerator at a dose rate of 2 Gy per day five times a week up to a dose of 60-70 Gy. In the study arm, patients were advised to take 20 ml of pure honey 15 min before, 15 min after and 6 h post-radiation therapy. Patients were evaluated every week for the development of radiation mucositis using the Radiation Therapy Oncology Group (RTOG) grading system.
MAIN RESULTS: There was significant reduction in the symptomatic grade 3/4 mucositis among honey-treated patients compared to controls; i.e. 20% versus 75% ( p 0.00058). The compliance of honey-treated group of patients was better than controls. Fifty-five percent of patients treated with topical honey showed no change or a positive gain in body weight compared to 25% in the control arm ( p 0.053), the majority of whom lost weight.
CONCLUSIONS: Topical application of natural honey is a simple and cost-effective treatment in radiation mucositis, which warrants further multi-centre randomised trials to validate our finding.

Matched MeSH terms: Radiation Injuries/therapy*
Complication and remission rates after endoscopic argon plasma coagulation in the treatment of haemorrhagic radiation proctitis

Siow SL, Mahendran HA, Seo CJ

Int J Colorectal Dis, 2017 Jan;32(1):131-134.
PMID: 27527929 DOI: 10.1007/s00384-016-2635-1

PURPOSE: The management of haemorrhagic radiation proctitis is challenging because of the necessity for repeated intervention. The efficacy of argon plasma coagulation has been described before but the optimum treatment strategy remains debatable. This is a review of our experience over a decade treating patients with haemorrhagic radiation proctitis and their follow-up.
METHODS: This is a retrospective review of consecutive patients who underwent argon plasma coagulation for haemorrhagic radiation proctitis between January 2003 and December 2013. The patients were followed up using a prospectively maintained database.
RESULTS: Ninety-one patients were included with a mean follow-up of 13.1 months. Majoity (n = 85, 93.4 %) of the patients were female. Mean age at the time of treatment was 58.2 (range 23-87) years old. Majority of the patients (n = 73, 80.2 %) received radiotherapy for gynaecological malignancies followed by colorectal (n = 13, 14.3 %) and urological (n = 5, 5.5 %) malignancies. Mean interval between radiation and proctitis was 13.8 (range 3-40) months. Seventy-nine percent of patients were successfully treated after 1-2 sessions. Seventeen (18.7 %) patients experienced self-limiting early complications, and three (3.3 %) had late complications of rectal stenosis which was managed conservatively. Severity of bleeding during the initial presentation is an independent factor that predicts the number of sessions required for successful haemostasis (p = 0.002).
CONCLUSIONS: Argon plasma coagulation is a reasonable treatment option in patients with haemorrhagic radiation proctitis with good safety profile. Our study suggests that the number of APC sessions required to arrest bleeding correlates with the severity of bleeding on initial presentation.

Matched MeSH terms: Radiation Injuries/therapy*
Velopharyngeal stenosis, a late complication of radiotherapy

Lee SC, Tang IP, Singh A, Kumar SS, Singh S

Auris Nasus Larynx, 2009 Dec;36(6):709-11.
PMID: 19304419 DOI: 10.1016/j.anl.2009.02.002

Choanal stenosis has recently been recognized as a late complication of radiation therapy for nasopharyngeal carcinoma. The management of velopharyngeal stenosis is challenging with high risk of restenosis. We report a case of velopharyngeal stenosis post-radiotherapy and illustrated the use of mitomycin-C to prevent restenosis. Mitomycin-C application has being shown useful adjunct to surgical technique in managing nasopharyngeal stenosis for surgeons.

Matched MeSH terms: Radiation Injuries/therapy
Managing complications of radiation therapy in head and neck cancer patients: Part II. Management of radiation-induced caries

Chai WL, Ngeow WC, Ramli R, Rahman RA

Singapore Dent J, 2006 Dec;28(1):4-6.
PMID: 17378334

Head and neck cancer is becoming a more recognizable pathology to the general population and dentists. The modes of treatment include surgery and/or radiation therapy. Where possible, pretreatment dental assessment shall be provided for these patients before they undergo radiation therapy. There are occasions, however, whereby head and neck cancer patients are not prepared optimally for radiation therapy. Because of this, they succumb to complicated oral complications after radiation therapy. The management of xerostomia has been reviewed in Part I of this series. In this article, the management of dental caries, a sequalae of xerostomia following radiation therapy is reviewed.

Matched MeSH terms: Radiation Injuries/therapy*
Radioprotective activity of Polyalthia longifolia standardized extract against X-ray radiation injury in mice

Jothy SL, Saito T, Kanwar JR, Chen Y, Aziz A, Yin-Hui L, et al.

Phys Med, 2016 Jan;32(1):150-61.
PMID: 26526749 DOI: 10.1016/j.ejmp.2015.10.090

The radioprotective effect of Polyalthia longifolia was studied in mice. P. longifolia treatment showed improvement in mice survival compared to 100% mortality in the irradiated mice. Significant increases in hemoglobin concentration, and red blood cell, white blood cell and platelet counts were observed in the animals pretreated with leaf extract. Pre-irradiation administration of P. longifolia leaf extract also increased the CFU counts of the spleen colony and increased the relative spleen size. A dose-dependent decrease in lipid peroxidation levels was observed in the animals pretreated with P. longifolia. However, although the animals pretreated with P. longifolia exhibited a significant increase in superoxide dismutase and catalase activity, the values remained below normal in both liver and the intestine. Pre-irradiation administration of P. longifolia also resulted in the regeneration of the mucosal crypts and villi of the intestine. Moreover, pretreatment with P. longifolia leaf extract also showed restoration of the normal liver cell structure and a significant reduction in the elevated levels of ALT, AST and bilirubin. These results suggested the radioprotective ability of P. longifolia leaf extract, which is significant for future investigation for human applications in developing efficient, economically viable, non-toxic natural and clinically acceptable novel radioprotectors.

Matched MeSH terms: Radiation Injuries/therapy*